| # | Drug | Count |
|---|---|---|
| 0 | GLUCAGON | 6 |
| 1 | OCTREOTIDE ACETATE | 5 |
| 2 | DICLOFENAC | 3 |
| 3 | DICLOFENAC SODIUM | 3 |
| 4 | OCTREOTIDE | 3 |
| 5 | ACITRETIN | 2 |
| 6 | BEVACIZUMAB | 2 |
| 7 | ERLOTINIB HYDROCHLORIDE | 2 |
| 8 | FLUOROURACIL | 2 |
| 9 | FLUOROURACIL CREAM, 0.5% | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DASIGLUCAGON | 1 | 0.0185 |
| 1 | GLUCAGON | 6 | 0.0014 |
| 2 | DIAZOXIDE | 1 | 0.0014 |
| 3 | PASIREOTIDE | 1 | 0.0004 |
| 4 | ACITRETIN | 2 | 0.0004 |
| 5 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0002 |
| 6 | LUTETIUM LU 177 DOTATATE | 1 | 0.0002 |
| 7 | OCTREOTIDE ACETATE | 5 | 0.0002 |
| 8 | ERLOTINIB HYDROCHLORIDE | 2 | 0.0002 |
| 9 | LANREOTIDE ACETATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 6 | 0.0014 |
| 1 | Somatostatin Analog [EPC] | 3 | 0.0004 |
| 2 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 7 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Retinoid [EPC] | 2 | 0.0000 |